In the present study, we aimed to study APOA5 genetic variation in relation to CAD, as well as the detailed lipoprotein profile, separately and in combination with variation in LPL and LDL-C-lowering through factorial genetic analyses in multiple cohorts. Here, LPL is linked to coronary artery disorder.